Literature DB >> 22265822

CHO cells expressing the human P₅-ATPase ATP13A2 are more sensitive to the toxic effects of herbicide paraquat.

Felicitas de Tezanos Pinto1, Gerardo Raul Corradi, Diego Pablo de la Hera, Hugo Pedro Adamo.   

Abstract

P-ATPases are membrane transporters energized by ATP. The subfamily of P₅-ATPases is the least studied P-ATPases and the ion substrate specificity of the P₅ subfamily is not known. Mutations of the human P₅ATPase gene ATP13A2 has been shown to underlie a form of Parkinson disease (PD). We investigated the link between ATP13A2 and environmental factors related to PD development. Increasing concentrations of the synthetic polyamine analog paraquat induced a greater cytotoxic effect over CHO cells expressing ATP13A2. Paraquat-toxicity was associated with increased production of cellular reactive oxygen species and this increment was reversed by the natural polyamine spermidine. Acridine orange fluorescence intensity suggested that ATP13A2 induced the expansion of acidic vesicles that become more alkaline upon external addition of spermidine. Polyamine uptake is proposed to be initiated by a plasma membrane carrier followed by sequestration into acidic vesicles of the late endocytic compartment through an unidentified active mechanism; because ATP13A2 is located in lysosomes and late endosomes, our results open the possibility that ATP13A2 could be one of those active transporters capable of transporting polyamines like spermidine as well as its toxic analog paraquat. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265822     DOI: 10.1016/j.neuint.2012.01.002

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  5 in total

1.  ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Authors:  Meenu Madan; Arjun Patel; Kristen Skruber; Dirk Geerts; Deborah A Altomare; Otto Phanstiel Iv
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

2.  Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.

Authors:  Jin-Sung Park; Brianada Koentjoro; David Veivers; Alan Mackay-Sim; Carolyn M Sue
Journal:  Hum Mol Genet       Date:  2014-01-07       Impact factor: 5.121

Review 3.  Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.

Authors:  Sarah van Veen; Danny M Sørensen; Tine Holemans; Henrik W Holen; Michael G Palmgren; Peter Vangheluwe
Journal:  Front Mol Neurosci       Date:  2014-05-27       Impact factor: 5.639

4.  Parkinson disease related ATP13A2 evolved early in animal evolution.

Authors:  Danny Mollerup Sørensen; Tine Holemans; Sarah van Veen; Shaun Martin; Tugce Arslan; Ida Winther Haagendahl; Henrik Waldal Holen; Norin Nabil Hamouda; Jan Eggermont; Michael Palmgren; Peter Vangheluwe
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

5.  ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.

Authors:  Stephanie Vrijsen; Laura Besora-Casals; Sarah van Veen; Jeffrey Zielich; Chris Van den Haute; Norin Nabil Hamouda; Christian Fischer; Bart Ghesquière; Ivailo Tournev; Patrizia Agostinis; Veerle Baekelandt; Jan Eggermont; Eric Lambie; Shaun Martin; Peter Vangheluwe
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.